+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aptevo Therapeutics Inc - logo
PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2026 - Product Thumbnail Image

PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2026

  • Report
  • November 2017
  • 413 Pages
From
Irritable Bowel Syndrome - Pipeline Drugs and Companies, Q2 2019 - Product Thumbnail Image

Irritable Bowel Syndrome - Pipeline Drugs and Companies, Q2 2019

  • Report
  • April 2019
  • 125 Pages
From
US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025 - Product Thumbnail Image

US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025

  • Report
  • April 2019
  • 300 Pages
From
Tumor Necrosis Factor Receptor Superfamily Member 9 - Pipeline Review, H2 2019 - Product Thumbnail Image

Tumor Necrosis Factor Receptor Superfamily Member 9 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 169 Pages
From
Tumor Necrosis Factor Receptor Superfamily Member 4 - Pipeline Review, H2 2019 - Product Thumbnail Image

Tumor Necrosis Factor Receptor Superfamily Member 4 - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 89 Pages
From
Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030 - Product Thumbnail Image

Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

  • Report
  • October 2019
  • 302 Pages
From
Lyophilization Services for Biopharmaceuticals, 2017-2027 - Product Thumbnail Image

Lyophilization Services for Biopharmaceuticals, 2017-2027

  • Report
  • April 2017
  • 239 Pages
From
Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) - Pipeline Review, H2 2018 - Product Thumbnail Image

Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) - Pipeline Review, H2 2018

  • Drug Pipelines
  • October 2018
  • 109 Pages
From
Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) - Pipeline Review, H1 2018 - Product Thumbnail Image

Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) - Pipeline Review, H1 2018

  • Drug Pipelines
  • April 2018
  • 99 Pages
From
RON (Recepteur d'origine Nantais) Inhibitor -Pipeline Insight, 2019 - Product Thumbnail Image

RON (Recepteur d'origine Nantais) Inhibitor -Pipeline Insight, 2019

  • Drug Pipelines
  • January 2019
  • 60 Pages
From
Recombinant Plasma Protein Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026 - Product Thumbnail Image

Recombinant Plasma Protein Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • Report
  • March 2019
  • 203 Pages
From
Global Hematology Partnering 2014-2019: Deal trends, players and financials - Product Thumbnail Image

Global Hematology Partnering 2014-2019: Deal trends, players and financials

  • Report
  • December 2019
  • 170 Pages
From
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2019 - Product Thumbnail Image

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2019

  • Report
  • October 2019
  • 350 Pages
From
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2019 - Product Thumbnail Image

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2019

  • Report
  • October 2019
  • 2300 Pages
From
Global Pharmaceutical Partnering Terms and Agreements 2014-2019: Deal trends, players and financials - Product Thumbnail Image

Global Pharmaceutical Partnering Terms and Agreements 2014-2019: Deal trends, players and financials

  • Report
  • September 2019
  • 3600 Pages
From
Cognitive Impairment Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Cognitive Impairment Disorders Drug Development Pipeline Review, 2018

  • Report
  • April 2018
  • 376 Pages
From
Bone Marrow Transplant Rejection - Pipeline Review, H1 2019 - Product Thumbnail Image

Bone Marrow Transplant Rejection - Pipeline Review, H1 2019

  • Drug Pipelines
  • May 2019
  • 653 Pages
From
Transplant Complications Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Transplant Complications Drug Development Pipeline Review, 2018

  • Report
  • November 2018
  • 173 Pages
From
PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars - 2018 Edition - Product Thumbnail Image

PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars - 2018 Edition

  • Report
  • December 2018
  • 74 Pages
From
Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2019 - Product Thumbnail Image

Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2019

  • Report
  • September 2019
  • 900 Pages
From
Loading Indicator
adroll